Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection

NCT04600141 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

308

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Tocilizumab
DRUG: Heparin - Therapeutic dosage
DRUG: Heparin - Prophylactic dosage

Sponsor

University of Sao Paulo

Collaborators

[object Object]